JP2025505781A5 - - Google Patents
Info
- Publication number
- JP2025505781A5 JP2025505781A5 JP2024548470A JP2024548470A JP2025505781A5 JP 2025505781 A5 JP2025505781 A5 JP 2025505781A5 JP 2024548470 A JP2024548470 A JP 2024548470A JP 2024548470 A JP2024548470 A JP 2024548470A JP 2025505781 A5 JP2025505781 A5 JP 2025505781A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- tablet
- buspirone
- release
- tablet according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310677P | 2022-02-16 | 2022-02-16 | |
| US63/310,677 | 2022-02-16 | ||
| PCT/US2023/013139 WO2023158694A1 (en) | 2022-02-16 | 2023-02-15 | Trimodal, precision-timed release tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505781A JP2025505781A (ja) | 2025-02-28 |
| JP2025505781A5 true JP2025505781A5 (enExample) | 2026-02-24 |
Family
ID=87579044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024548470A Pending JP2025505781A (ja) | 2022-02-16 | 2023-02-15 | 三峰性の精密時限放出型錠剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250177310A1 (enExample) |
| EP (1) | EP4479028A4 (enExample) |
| JP (1) | JP2025505781A (enExample) |
| KR (1) | KR20240150485A (enExample) |
| CN (1) | CN118829422A (enExample) |
| AU (1) | AU2023222759A1 (enExample) |
| CA (1) | CA3252172A1 (enExample) |
| IL (1) | IL314820A (enExample) |
| WO (1) | WO2023158694A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8704097D0 (sv) * | 1987-10-22 | 1987-10-22 | Astra Ab | Oral formulation of buspirone and salts thereof |
| US20090297597A1 (en) * | 1998-11-02 | 2009-12-03 | Gary Liversidge | Modified Release Ticlopidine Compositions |
| JP2002541092A (ja) * | 1999-04-06 | 2002-12-03 | ファーマクエスト・リミテッド | メチルフェニデートのパルス性送達のための薬学的投薬形態 |
| CN100551373C (zh) * | 2005-12-01 | 2009-10-21 | 北京华素制药股份有限公司 | 盐酸丁螺环酮缓/控释微丸 |
| EP1970055B1 (en) * | 2005-12-29 | 2010-11-24 | Osmotica Kereskedelmi És Szolgáltató Kft | Multi-layered tablet with triple release combination |
| PT2838517T (pt) * | 2012-04-18 | 2018-01-04 | Contera Pharma Aps | Formulação farmacêutica disponível sob forma oral adequada para a melhoria da gestão dos distúrbios da mobilidade |
| JP2018506590A (ja) * | 2015-02-27 | 2018-03-08 | シンギュレイト・セラピューティクス・リミテッド・ライアビリティ・カンパニーＣｉｎｇｕｌａｔｅ Ｔｈｅｒａｐｅｕｔｉｃｓ ＬＬＣ | トリパルス放出型賦活薬製剤 |
-
2023
- 2023-02-15 US US18/838,775 patent/US20250177310A1/en active Pending
- 2023-02-15 AU AU2023222759A patent/AU2023222759A1/en active Pending
- 2023-02-15 KR KR1020247030975A patent/KR20240150485A/ko active Pending
- 2023-02-15 EP EP23756849.8A patent/EP4479028A4/en active Pending
- 2023-02-15 CN CN202380021979.8A patent/CN118829422A/zh active Pending
- 2023-02-15 IL IL314820A patent/IL314820A/en unknown
- 2023-02-15 CA CA3252172A patent/CA3252172A1/en active Pending
- 2023-02-15 WO PCT/US2023/013139 patent/WO2023158694A1/en not_active Ceased
- 2023-02-15 JP JP2024548470A patent/JP2025505781A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hermida et al. | Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure | |
| CN105101956B (zh) | 包含双胍的延迟释放组合物 | |
| JP2017128614A5 (enExample) | ||
| JP2024540183A5 (enExample) | ||
| CN104349773A (zh) | 用于治疗代谢性病症的组合物和方法 | |
| JP2024102139A5 (enExample) | ||
| JP2022504182A5 (enExample) | ||
| TW201740932A (zh) | 美沙拉 的口服醫藥組成物 | |
| US20260069543A1 (en) | Controlled-release tablet of ibuprofen and its use for relieving pain | |
| JP2023523706A5 (enExample) | ||
| BG65637B1 (bg) | Използване на мелатонин във форма с контролирано освождаване за лечение на резистентност към антихипертензивни препарати и подобни състояния | |
| EP1896076A2 (en) | Compositions and methods for enhancement of sexual function | |
| JP4786127B2 (ja) | 色素沈着改善治療薬 | |
| JP2021001190A (ja) | トリパルス放出型賦活薬製剤 | |
| JP2025517509A5 (enExample) | ||
| CN102058591A (zh) | 一种左旋氨氯地平和替米沙坦的复方制剂 | |
| KR102055894B1 (ko) | 제2형 당뇨병 및 당뇨성 이상지질혈증 치료용 복합제제 | |
| JP2021530568A5 (enExample) | ||
| Carter | Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events | |
| JP2024506041A5 (enExample) | ||
| Çetin | Fixed-dose combination-orally disintegrating tablet (FDC-ODT) studies for the treatment of type 2 diabetes or cardiovascular diseases-a mini review | |
| US20250177310A1 (en) | Trimodal, precision-timed release tablet | |
| CA2403350A1 (en) | Use of deramciclane for the treatment of anxiety and depression | |
| KR20240006643A (ko) | 삼봉 정밀-시한 펄스형 방출 정제 | |
| HK40108332B (en) | Trimodal, precision-timed pulsatile release tablet |